Search Results - Foli, Andrea

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Complementary Antiviral Efficacy of Hydroxyurea and Protease Inhibitors in Human Immunodeficiency Virus-Infected Dendritic Cells and Lymphocytes

    Complementary Antiviral Efficacy of Hydroxyurea and Protease Inhibitors in Human Immunodeficiency Virus-Infected Dendritic Cells and Lymphocytes by Piccinini, Giampiero, Foli, Andrea, Comolli, Giuditta, Lisziewicz, Julianna, Lori, Franco

    Published 2002
    Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis

    A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis by Palladini, Giovanni, Russo, Paola, Milani, Paolo, Foli, Andrea, Lavatelli, Francesca, Nuvolone, Mario, Perlini, Stefano, Merlini, Giampaolo

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis

    Sequential response-driven bortezomib-based therapy followed by autologous stem cell transplant in AL amyloidosis by Basset, Marco, Milani, Paolo, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach

    Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach by Palladini, Giovanni, Milani, Paolo, Foli, Andrea, Obici, Laura, Lavatelli, Francesca, Nuvolone, Mario, Caccialanza, Riccardo, Perlini, Stefano, Merlini, Giampaolo

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy

    Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy by Milani, Paolo, Basset, Marco, Nuvolone, Mario, Benigna, Francesca, Rodigari, Lara, Lavatelli, Francesca, Foli, Andrea, Merlini, Giampaolo, Palladini, Giovanni

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function

    Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function by Milani, Paolo, Basset, Marco, Curci, Paola, Foli, Andrea, Rizzi, Rita, Nuvolone, Mario, Guido, Raffaella, Gesualdo, Loreto, Specchia, Giorgina, Merlini, Giampaolo, Palladini, Giovanni

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Protease‐sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation

    Protease‐sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation by Mazzini, Giulia, Ricagno, Stefano, Caminito, Serena, Rognoni, Paola, Milani, Paolo, Nuvolone, Mario, Basset, Marco, Foli, Andrea, Russo, Rosaria, Merlini, Giampaolo, Palladini, Giovanni, Lavatelli, Francesca

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences

    Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences by Shepard, Brett D., De Forni, Davide, McNamara, David R., Foli, Andrea, Rizza, Stacey A., Abraham, Roshini S., Knutson, Keith, Wettstein, Peter J., Lori, Franco, Badley, Andrew D.

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis

    A validated composite organ and hematologic response model for early assessment of treatment outcomes in light chain amyloidosis by Sidana, Surbhi, Milani, Paolo, Binder, Moritz, Basset, Marco, Tandon, Nidhi, Foli, Andrea, Dispenzieri, Angela, Gertz, Morie A., Hayman, Suzanne R., Buadi, Francis K., Lacy, Martha Q., Kapoor, Prashant, Leung, Nelson, Rajkumar, S. Vincent, Merlini, Giampaolo, Palladini, Giovanni, Kumar, Shaji K.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis

    Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis by Palladini, Giovanni, Paiva, Bruno, Wechalekar, Ashutosh, Massa, Margherita, Milani, Paolo, Lasa, Marta, Ravichandran, Sriram, Krsnik, Isabel, Basset, Marco, Burgos, Leire, Nuvolone, Mario, Lecumberri, Ramón, Foli, Andrea, Puig, Noemi, Sesta, Melania Antonietta, Bozzola, Margherita, Cascino, Pasquale, Nevone, Alice, Ripepi, Jessica, Berti, Pierpaolo, Casarini, Simona, Annibali, Ombretta, Orfao, Alberto, San-Miguel, Jesus, Merlini, Giampaolo

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: